| Primary | Fidelity/Adherence Via Subject Diary | Evaluate the feasibility and potential effectiveness of the Flexitouch head and neck garments by monitoring fidelity/adherence using a subject diary. Values represent a count of participants who met the prescribed use criteria by week. The prescribed use was defined as two 30 minute sessions in a day. | This analysis only applies to the Interventional Group. | Posted | | Count of Participants | | Participants | | From baseline to end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| | | Title | Denominators | Categories |
|---|
| Week 1 | | | Title | Measurements |
|---|
| 0 days | | | 1 day | | | 2 days | |
|
| |
| Primary | Adverse Events | Evaluate the feasibility and potential effectiveness of the Flexitouch head and neck garments by monitoring adverse events using the CTCAE (v4.0). Values represent the count of events per adverse events category. | | Posted | | Number | | Events | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Wait-list Control Group | Standard home lymphedema care: May include daily self manual lymphatic drainage, exercise, skincare, compression garments (as appropriate). | | OG001 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| |
| Primary | Treatment Satisfaction | Evaluate the feasibility and potential effectiveness of the Flexitouch head and neck garments by monitoring treatment satisfaction using a satisfaction survey. A survey assessed participants' perceived ability to control their head and neck lymphedema before (at baseline) and after the usage of the Flexitouch at 8 weeks. Values represent a count of participants who indicated good, very good, or excellent. | This only applied to participants in the interventional group who had indicated good, very good, or excellent in regards to their perceived ability to control their head and neck lymphedema. | Posted | | Count of Participants | | Participants | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| |
| Secondary | Reduction in Swelling/Inflammation - Endoscopy | The change in percent of sites with visible swelling and inflammation as assessed via endoscopy (using Modified Patterson Scale) from baseline to week 8. The range for each anatomical structure includes 1-4: Normal, Mild, Moderate, and Severe. A lower score means a better outcome. A greater negative value indicates a greater reduction in swelling. Total score range: 0-100%. | | Posted | | Median | Inter-Quartile Range | Change in score | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Wait-list Control Group | Standard home lymphedema care: May include daily self manual lymphatic drainage, exercise, skincare, compression garments (as appropriate). | | OG001 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| |
| Secondary | Reduction in Swelling/Inflammation - Cytokine Levels | The presence of swelling and inflammation was assessed in all participants via the change in cytokine levels of Interleukin 6 (IL-6) at baseline to week 8. A lower score means a better outcome. A greater negative value indicates a greater reduction in cytokine levels. | Not all participants' blood samples were analyzable. | Posted | | Median | Inter-Quartile Range | fg/ml | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Wait-list Control Group | Standard home lymphedema care: May include daily self manual lymphatic drainage, exercise, skincare, compression garments (as appropriate). | | OG001 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| |
| Secondary | Reduction in Swelling/Inflammation - Digital Photography | The presence of swelling and inflammation was assessed in all participants by digital photography at baseline and 8 weeks. A lower value means a better outcome. A greater negative value indicates a greater reduction in swelling. Three views were scored each with 30 grids. The percentage of views with visible swelling was determined. The score ranged from 0-100%. | | Posted | | Median | Inter-Quartile Range | score on a scale | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Wait-list Control Group | Standard home lymphedema care: May include daily self manual lymphatic drainage, exercise, skincare, compression garments (as appropriate). | | OG001 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| |
| Secondary | Reduction in Swelling/Inflammation - Grading of External Lymphedema | The presence of swelling and inflammation was assessed in all participants through grading of external lymphedema via the Head and Neck Lymphedema and Fibrosis Assessment criteria (HNLEF) during a physical examination at baseline and 8 weeks. A total of 9 sites were evaluated for the presence of lymphedema and graded from 1 (mild) to 3 (severe) at each site. The number of sites ranged from 0-9 with a total severity score ranging from 0-27. Results are the change in a total score between baseline and 8 weeks. A lower score indicates a better outcome. A greater negative value indicates a greater reduction in swelling. | | Posted | | Median | Inter-Quartile Range | score on a scale | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Wait-list Control Group | Standard home lymphedema care: May include daily self manual lymphatic drainage, exercise, skincare, compression garments (as appropriate). | | OG001 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| |
| Secondary | Function - Jaw Range of Motion | The function was assessed in all participants at baseline and week 8 through the jaw range of motion measurements using the Therabite Jaw ROM Scale. The TheraBite Jaw ROM Scale was used to measure in millimeters the jaw opening of the maximum inter-incisal distance (upper right central to lower right central incisor). The values were categorized by grade change. The change of -1 indicates the severity improved by one grade. A value of zero indicates a participant remained stable. A value of 1 indicates a patient worsened by one grade. | | Posted | | Count of Participants | | Participants | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Wait-list Control Group | Standard home lymphedema care: May include daily self manual lymphatic drainage, exercise, skincare, compression garments (as appropriate). | | OG001 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| |
| Secondary | Function - Neck Disability Index | The function was assessed in all participants at baseline and week 8 by the Neck Disability Index (NDI). Values represent a change from baseline. Minimum score: 0 with a minimum disability of 0%. Maximum score: 50 with a maximal disability of 100%. 0 - 20% (minimal) - The patient can cope with most living activities. Usually, no treatment is indicated apart from advice on lifting sitting and exercise. 21 - 40% (moderate) - The patient experiences more pain and difficulty with sitting lifting and standing. Travel and social life are more difficult and they may be disabled from work. The patient can usually be managed by conservative means. 41 - 60% (severe) -Pain remains the main problem in this group but activities of daily living are affected. These patients require a detailed investigation. 61 - 80% (crippled) - Pain impinges on all aspects of the patient's life. Positive intervention is required. 81 - 100% (bed bound) - Need to exclude exaggeration or malingering. | | Posted | | Median | Inter-Quartile Range | score on a scale | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Wait-list Control Group | Standard home lymphedema care: May include daily self manual lymphatic drainage, exercise, skincare, compression garments (as appropriate). | | OG001 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
|
| Secondary | Function - Voice Handicap Index | The function was assessed in all participants at baseline and week 8 by the Voice Handicap Index (VHI). Values represent a change from baseline. Max / Min Total Score: 0-120. A lower score indicates a better outcome. | | Posted | | Median | Inter-Quartile Range | score on a scale | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Wait-list Control Group | Standard home lymphedema care: May include daily self manual lymphatic drainage, exercise, skincare, compression garments (as appropriate). | | OG001 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| |
| Secondary | Function - Cervical and Shoulder Range of Motion | The function was assessed in all participants at baseline and week 8 through the cervical range of motion (CROM) and shoulder range of motion (SROM) measurements. A positive value indicates a better outcome. The greater the value, the greater the change from baseline. | | Posted | | Median | Inter-Quartile Range | Degrees | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Wait-list Control Group | Standard home lymphedema care: May include daily self manual lymphatic drainage, exercise, skincare, compression garments (as appropriate). | | OG001 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| |
| Secondary | Symptoms - Vanderbilt Head and Neck Symptom Survey | Symptoms were assessed in all participants at baseline and week 8 via the Vanderbilt Head and Neck Symptom Survey plus General Symptom Survey (VHNSS v2.0 plus GSS). Values represent a median score change from baseline. Score range: 0-10. A lower score indicates a better outcome. A more negative value indicates a greater change from baseline. Given this was a self-reported survey, responses were not mandatory and thus missing for some subjects. | Data was not available and/or applicable to all participants in certain categories. | Posted | | Median | Inter-Quartile Range | score on a scale | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Wait-list Control Group | Standard home lymphedema care: May include daily self manual lymphatic drainage, exercise, skincare, compression garments (as appropriate). | | OG001 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| |
| Secondary | Quality of Life - Linear Analog Self-Assessment | Quality of life was assessed in all participants at baseline and week 8 using the Linear Analog Self-Assessment. The total score for the assessment ranged from 0-50. Each category represents a change in score from the baseline visit which ranged from positive 4 to negative 4. A positive change indicates an improvement. Values represent the count of participants in each category. | | Posted | | Count of Participants | | Participants | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Wait-list Control Group | Standard home lymphedema care: May include daily self manual lymphatic drainage, exercise, skincare, compression garments (as appropriate). | | OG001 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| |
| Secondary | Symptoms - Lymphedema Symptom Intensity and Distress Survey | Lymphedema Symptom Intensity and Distress Survey-Head and Neck (LSIDS-HN) assessed the measurement characteristics of a symptom burden for participants with head and neck lymphedema at baseline and week 8. Each symptom was rated on intensity and distress using a 5-point scale. A maximum response for any symptom within a given cluster was used for the analysis. The total score ranged from 0-10. The values represent a change from baseline. A lower score means a better outcome. | Data may be missing or left blank by participant. | Posted | | Median | Inter-Quartile Range | score on a scale | | From baseline to the end of treatment at 8 weeks | | | | ID | Title | Description |
|---|
| OG000 | Wait-list Control Group | Standard home lymphedema care: May include daily self manual lymphatic drainage, exercise, skincare, compression garments (as appropriate). | | OG001 | Interventional Group | Twice daily treatment with Flexitouch® pneumatic compression device and home care regimen, which may include self-MLD exercise, skincare, and wearing an appropriate compression garment, if applicable. |
| |